Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
Submitted by
admin
on May 31, 2013 - 4:37pm
Source:
Yahoo
News Tags:
type 1 diabetes
MannKind
Afrezza
inhaled insulin
Headline:
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 1 Diabetes
Do Not Allow Advertisers to Use My Personal information
